Skip to main content

Table 2 Number of patients who were exposed to statins and other lipid lowering agents

From: Effect of statins on fasting glucose in non-diabetic individuals: nationwide population-based health examination in Korea

Medication

Number (%) of patients who had exposure to medication

Cumulative duration (years) of exposure to medication

Any statin

96,182 (25.3)

165,083

 Atorvastatin

61,157 (16.1)

78,627

 Rosuvastatin

11,720 (3.1)

14,678

 Pitavastatin

8010 (2.1)

7691

 Pravastatin

8047 (2.1)

8099

 Simvastatin

46,773 (12.3)

46,768

 Lovastatin

9291 (2.4)

6045

 Fluvastatin

3786 (1.0)

3175

Fibratea

14,926 (3.9)

11,617

Ezetimibe

5847 (1.5)

5830

  1. Data are based on time period between baseline and last health examination of each subject
  2. aBezafibrate, ciprofibrate, etofibrate, fenofibrate, and gemfibrozil
Back to article page

Cardiovascular Diabetology

ISSN: 1475-2840